About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in San Francisco | 5,259 Studies Near You

Clinical TrialsSan Francisco

Clinical Trials in San Francisco

Discover 5,259 clinical trials near San Francisco, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1441-1460 of 5,259 trials

CompletedLung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung CancerThis phase II trial studies how well talazoparib works in treating patients with homologous recombination repair deficiency (HRRD) positive stage IV squamous cell lung cancer that…NCT03377556·Birmingham, Alabama and 1156 others

Find Trials by Condition in San Francisco

Breast Cancerin San Francisco Lung Cancerin San Francisco Prostate Cancerin San Francisco Colorectal Cancerin San Francisco Melanomain San Francisco Leukemiain San Francisco Lymphomain San Francisco Pancreatic Cancerin San Francisco Ovarian Cancerin San Francisco Brain Cancerin San Francisco

Data from ClinicalTrials.govTerms

CompletedParkinson's Research: The Organized Genetics InitiativeThe purpose of this trial is to study genetic and other risk factors that may be important in the development of Parkinson's disease.NCT00086073·Phoenix, Arizona and 57 others

CompletedResponse to Acute Exercise in Eating DisordersIndividuals with eating disorders (ED) represent a high-priority clinical population, with among the highest mortality rates of any psychiatric disorder, and driven exercise (DEx)…NCT06213883·San Francisco, California and 1 other

RecruitingExercise Intolerance in Non-obstructive Hypertrophic CardiomyopathyThe EXCITE-HCM study is a randomized, controlled, blinded clinical trial designed to evaluate the effect of moderate intensity exercise training versus usual physicial activity on…NCT05818605·San Francisco, California

CompletedImpact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-StudyDespite the increasingly common use of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies in treating cystic fibrosis (CF), it is still largely unknown…NCT06350474·Birmingham, Alabama and 80 others

CompletedSaline-Controlled Study of nSTRIDE APS for Knee OsteoarthritisA double-blind, multicenter, randomized, controlled trial (RCT) that will evaluate the efficacy of a single dose of Autologous Protein Solution (APS) in patients with…NCT02905240·Birmingham, Alabama and 26 others

CompletedPROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXEDThe goal of this cluster randomized clinical trial is to test the efficacy of messaging interventions to increase booster vaccine uptake in adults in the emergency department(ED).NCT06156215·San Francisco, California and 6 others

CompletedClinical Evaluation of the i-STAT ACTpro Cartridge in an Adult PopulationMeasuring Activated Clotting Time (ACT) using the i-STAT ACTpro cartridge on the i-STAT 1 analyzer compared to a comparator device.NCT07382076·Chandler, Arizona and 10 others

CompletedSafety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's DiseaseSafety study of AADC gene transfer (VY-AADC01) in subjects with Parkinson's disease.NCT01973543·San Francisco, California and 1 other

RecruitingA Study of IBI363 in Subjects with Advanced Solid MalignanciesThis is a Phase 2, open-label, multicenter study designed to evaluate the efficacy, safety and tolerability of IBI363 (study drug) in subjects with advanced, refractory solid…NCT06281678·San Francisco, California and 8 others

TerminatedFocused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic SarcomaThis study is a single site, single-arm, feasibility study to evaluate the safety and efficacy of MRgFUS using the ExAblate 2100 System for the partial ablation of…NCT04123535·San Francisco, California

Active not recruitingTreatment for Speech and Language in Primary Progressive AphasiaPrimary progressive aphasia (PPA) is a progressive neurological disorder that causes a gradual decline in communication ability as a result of selective neurodegeneration of…NCT04881617·San Francisco, California and 1 other

CompletedTailored Antiplatelet Therapy Following PCIClopidogrel is an anti-platelet medication approved by the U.S. Federal Drug Administration (FDA) for use in patients who undergo Percutaneous Coronary Intervention (PCI) with…NCT01742117·Scottsdale, Arizona and 40 others

CompletedActivating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness StudyThis trial consists of two linked substudies.NCT01144104·Elk Grove, California and 5 others

Active not recruitingFutibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.This is a nonrandomized, open-label, multicenter rollover study for patients who received futibatinib as monotherapy or as combination therapy in a Taiho-sponsored futibatinib…NCT06506955·San Francisco, California and 8 others

CompletedSpironolactone Therapy In Young Women With NASHNonalcoholic steatohepatitis (NASH), or fat-related liver inflammation and scarring is projected to be the leading cause of cirrhosis in the United States (U.S.) within the next…NCT03576755·San Francisco, California

TerminatedNEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis PatientsThe goal of this pilot, randomized, single-blind clinical trial is to estimate the effect size of a high and low mean arterial pressure (MAP)-target algorithm among cirrhosis…NCT06000748·San Francisco, California

UnknownPaclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the EsophagusRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003326·Mobile, Alabama and 29 others

CompletedVedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)The purpose of this study is to evaluate vedolizumab pharmacokinetics (PK), safety and tolerability in pediatric participants with moderately to severely active UC or CD.NCT03138655·Los Angeles, California and 87 others

TerminatedAtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic StrokeObjectives * Primary: To test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in patients with cryptogenic ischemic stroke and atrial…NCT03192215·Birmingham, Alabama and 176 others

PreviousPage 73 of 263Next

Diabetes

in San Francisco

Heart Diseasein San Francisco